Business
AbCellera and Bruker Reach Global Settlement of Patent Litigation
VANCOUVER, British Columbia, December 18, 2025--AbCellera and Bruker Reach Global Settlement of Patent Litigation
About this update from Bruker Corporation
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":480,"height":339,"url":"https://media.zenfs.com/en/business-wire.com/e86b24abdd9b7dfd2c523204a0c2ef7a"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/8qzXy6vup1FHjTyof6cMnA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTY3ODtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/e86b24abdd9b7dfd2c523204a0c2ef7a","width":480,"height":339}},"lazy":false},{"type":"text","content":"VANCOUVER, British Columbia, December 18, 2025--(BUSINESS WIRE)--AbCellera (Nasdaq: ABCL) today announced that it has entered into a settlement and patent license agreement with Bruker Corporation, resolving the patent litigation between the two companies globally. As part of the settlement, Bruker will pay AbCellera $36 million up front as well as future royalty payments on sales of Bruker's Beacon® Optofluidic platform products worldwide through the life of the licensed patents.","length":489,"tagName":"p"},{"type":"text","content":"About AbCellera Biologics Inc.","length":30,"tagName":"p"},{"type":"text","content":"AbCellera (Nasdaq: ABCL) is a clinical-stage biotechnology company focused on discovering and developing antibody-based medicines in the areas of endocrinology, women’s health, immunology, and oncology. For more information, please visit www.abcellera.com.","length":256,"tagName":"p"},{"type":"text","content":"AbCellera Forward-Looking Statements","length":36,"tagName":"p"},{"type":"text","content":"This press release contains forward-looking statements, including statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The forward-looking statements are based on management’s current beliefs and assumptions and on information currently available to management. All statements contained in this release other than statements of historical fact are forward-looking statements, including statements regarding our ability to develop, commercialize, and achieve market acceptance of our current and planned products and services, our research and development efforts, and other matters regarding our business strategies, use of capital, results of operations and financial position, and plans and objectives for future operations.","length":785,"tagName":"p"},{"type":"text","...